Combined BRAF-targeted and immunotherapy shows promise for melanoma treatment

Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new therapeutic approach for the treatment of melanoma, according to results of a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research.

Read the whole article on Physorg

More from Physorg